Literature DB >> 28631944

Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.

Shun-Ichi Kimura1, Ayumi Gomyo1, Jin Hayakawa1, Masaharu Tamaki1, Yu Akahoshi1, Naonori Harada1, Tomotaka Ugai1, Machiko Kusuda1, Kazuaki Kameda1, Hidenori Wada1, Yuko Ishihara1, Koji Kawamura1, Kana Sakamoto1, Miki Sato1, Kiriko Terasako-Saito1, Misato Kikuchi1, Hideki Nakasone1, Shinichi Kako1, Aki Tanihara1, Yoshinobu Kanda1.   

Abstract

BACKGROUND: We evaluated the clinical significance of repeat blood cultures in persistent and recurrent fever during neutropenia in adult acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) patients undergoing intensive chemotherapy.
METHODS: We retrospectively reviewed the chemotherapy cycles at our centre between January 2007 and December 2015. Blood cultures obtained within three days after initial febrile neutropenia (FN) were defined as initial blood cultures and those obtained on or after day 4 were defined as repeat blood cultures.
RESULTS: Overall, 321 chemotherapy cycles in 89 patients were subjected to review. FN was identified in 276 (86.0%) chemotherapy cycles. In persistent FN (134 episodes), the causative pathogens were detected by repeat blood cultures in seven episodes (5.2%), including only three episodes (2.2%) of new infection. Shaking chills and high body temperature were identified as significant predictors for bloodstream infection (BSI). In recurrent FN (85 episodes), the causative pathogens were detected in seven episodes (8.2%), and all of these were new organisms. The frequency of detecting new pathogens by repeat blood cultures in recurrent FN (7/85) was higher than that in persistent FN (3/134) (p = .0491). A history of recent BSI was identified as a significant predictor for BSI in recurrent FN.
CONCLUSIONS: The diagnostic yield of repeat blood cultures for persistent FN was low in intensive chemotherapy for AML and MDS. The frequency of repeat blood cultures for persistent FN could be reduced based on predictors. On the other hand, blood cultures were considered to be essential in cases with recurrent FN.

Entities:  

Keywords:  Repeat blood culture; acute myeloid leukaemia; febrile neutropenia; persistent fever; recurrent fever

Mesh:

Substances:

Year:  2017        PMID: 28631944     DOI: 10.1080/23744235.2017.1340665

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  3 in total

1.  Follow-up Blood Culture Practices for Gram-Negative Bloodstream Infections in Immunocompromised Hosts at a Large Academic Medical Center.

Authors:  Lauren Groft Buzzalino; James Mease; Ciera L Bernhardi; Jacqueline T Bork; J Kristie Johnson; Kimberly C Claeys
Journal:  Open Forum Infect Dis       Date:  2022-04-15       Impact factor: 4.423

Review 2.  Blood Culture Utilization in the Hospital Setting: a Call for Diagnostic Stewardship.

Authors:  Valeria Fabre; Karen C Carroll; Sara E Cosgrove
Journal:  J Clin Microbiol       Date:  2021-07-14       Impact factor: 11.677

3.  Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.

Authors:  Pinkal M Desai; Janice Brown; Saar Gill; Melham M Solh; Luke P Akard; Jack W Hsu; Celalettin Ustun; Charalambos Andreadis; Olga Frankfurt; James M Foran; John Lister; Gary J Schiller; Matthew J Wieduwilt; John M Pagel; Patrick J Stiff; Delong Liu; Irum Khan; Wendy Stock; Suman Kambhampati; Martin S Tallman; Lawrence Morris; John Edwards; Iskra Pusic; Hagop M Kantarjian; Richard Mamelok; Alicia Wong; Rodney Van Syoc; Lois Kellerman; Swapna Panuganti; Ramkumar Mandalam; Camille N Abboud; Farhad Ravandi
Journal:  J Clin Oncol       Date:  2021-06-22       Impact factor: 50.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.